The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries Upon Outcomes of Chronic Periodontitis

NCT ID: NCT01229631

Last Updated: 2019-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-22

Study Completion Date

2017-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine whether enhanced micronutrient intake in the form of fruit, vegetable and berry juice powder (FVB) concentrate, improves clinical outcomes in chronic periodontitis patients prior to standard non-surgical treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to determine whether enhanced micronutrient intake in the form of fruit, vegetable and berry juice powder (FVB) concentrate, improves clinical outcomes in chronic periodontitis patients prior to non-surgical treatment. In addition, the effects of supplementation prior to and following standard non-surgical management will be assessed, relative to a placebo supplemented group.

The investigators hypothesize that 3-months of nutritional support using this FVB will result in additional reductions in marginal gingival inflammation (bleeding) and additional reductions in probing pocket depth (mean \& cumulative), over and above any placebo-related or behavioral effect. In addition, the investigators hypothesize that 3-months of nutritional support prior to a standard non-surgical therapy in conjunction with a continuation of the nutritional support for 3 months will result in further additional reductions in marginal gingival inflammation and probing pocket depth, over and above any placebo-related or behavioral effect following standard non-surgical therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

longitudinal, randomised, block stratified (for smoking), double-blind, 2-arm interventional study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supplementation with non-active

Subjects will be supplemented with placebo capsules (3 capsules am \& 3 capsules pm)

Group Type PLACEBO_COMPARATOR

Placebo non active capsules

Intervention Type DIETARY_SUPPLEMENT

Subjects will take non-active placebo capsules (3 in the morning and 3 in the evening, for 3 months)

Dietary supplementation with Juice plus+

Subjects will be supplemented with Juice plus+ capsules (3 capsules am \& 3 capsules pm)

Group Type ACTIVE_COMPARATOR

Juice plus+

Intervention Type DIETARY_SUPPLEMENT

Subjects in active group will be supplemented with Juice plus+ capsules (3 in the morning and 3 in the evening, for 3 months)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Juice plus+

Subjects in active group will be supplemented with Juice plus+ capsules (3 in the morning and 3 in the evening, for 3 months)

Intervention Type DIETARY_SUPPLEMENT

Placebo non active capsules

Subjects will take non-active placebo capsules (3 in the morning and 3 in the evening, for 3 months)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be aged 18 years old and over
* have a minimum of 20 teeth
* have chronic periodontitis
* be capable of giving informed consent themselves

Exclusion Criteria

* Patients with aggressive disease
* Patients with physical or mental disability
* Pregnant women or those breastfeeding
* Patients whose medical history may place them at risk of complications from periodontal therapy (e.g. warfarinised Volunteers)
* Patients taking long term anti-microbial or anti-inflammatory drugs
* Patients unable to swallow the study capsules, or take 6 of these capsules a day
* Patients unable to provide informed consent
* Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils) or have taken them within 1-month of the study
* Shows unwillingness, inability or lack of motivation to carry out the study procedures or is not prepared to give written consent or to refrain from using other oral hygiene products (mouthwashes, chewing gum, water piks etc.) or to undergo professional dental cleaning for the duration of the study (other than as part of this protocol)
* Antibiotic or anti-inflammatory therapy currently or in previous two weeks
* Current orthodontic treatment
* Currently participating in another Dental Trial
* Diabetics
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Wuerzburg

OTHER

Sponsor Role collaborator

Academic Centre for Dentistry in Amsterdam

OTHER

Sponsor Role collaborator

Birmingham Community Healthcare NHS

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Professor I Chapple

Professor (PI to study)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iain L Chapple, BDS, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Birmingham

Ulrich Schlagenhauf, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wuerzburg

Ubele Van der Velden, PhD

Role: PRINCIPAL_INVESTIGATOR

Academic Centre for Dentistry in Amsterdam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wuerzburg

Würzburg, , Germany

Site Status

Academic Centre for Dentistry

Amsterdam, , Netherlands

Site Status

Birmingham Dental Hospital & School

Birmingham, West Midlands, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Netherlands United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MULTI-NSA-10-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.